A research report by MarkNtel Advisors on the Autoimmune Disorder Drug Delivery Devices Market brings together an in-depth understanding of the industry exhibiting all the aspects influencing the expansion in the historical years (2017 to 2020), the scenario of the base year (2021), and estimates of the forecast years (2022 to 2027) across different geographies.
This analysis is an unbiased, accurate, and reliable source of information for the stakeholders to understand the key parameters influencing the industry, like growth drivers, challenges, restraints, and opportunities, among others. The stakeholders can also attain data on the current trends, recent developments, investments & strategies, among other elements shaping the market dynamics and projecting its growth pace over the years & in the future.
Take A Free Sample PDF of This Report, To See The Full Structure of This Study Report – Download Now
Market Dynamic for Autoimmune Disorder Drug Delivery Devices Industry
Growth Driver – The selection of T-cells with increased affinity to self-antigens, and latent viruses, which result in the aging of the immune system, are the major factors contributing to an increase in autoimmune disorders in the elderly age population globally. According to the World Health Organization (WHO), the number of people aged over 60 is expected to nearly double from 12% to 22% by 2050.
|Study Period||Historical Data: 2017-20|
|Base Year: 2021|
|Forecast Period: 2022-27|
|Regions Covered||North America: USA, Canada, Mexico|
|Europe: Germany, UK, Germany, France, Italy, Spain, Others|
|Asia-Pacific: China, India, Japan, South Korea, Australia and Others|
|South America: Brazil, and Others|
|Middle East & Africa: UAE, Saudi Arabia, South Africa|
|Key Companies Profiled||Amgen Inc., AbbVie Inc., Bayer AG, Biogen Inc., Eli Lilly and Company, Bristol-Myers Squibb Company, F. Hoffmann-La Roche AG, GlaxoSmithKline plc, Johnson & Johnson Services, Inc., The Merck Group, Novartis International AG, Sanofi S.A., Teva Pharmaceutical Industries Ltd., UCB Pharma SA|
|Unit Denominations||USD Million/Billion|
Furthermore, globally, the aging population & increased immune disorders such as Alzheimer’s Disease, Rheumatoid Arthritis, diabetes, etc., combined with the decrease in gastric pH, which limits drug absorption, are leading to an increase in demand for autoimmune disorder drug delivery devices.
Upcoming Challenges – Autoimmune disorder drug delivery devices are regulated across different countries through various regulating bodies. The ISO standards for the prefilled syringes comprise several additional requirements for cGMP regulations, such as stability testing, special testing requirements, reserve samples, and other QSR regulations like purchasing controls, design controls, and corrective & preventive actions, among others. Moreover, due to these stringent regulations, companies face difficulty & delays in launching new products for autoimmune drug delivery. Furthermore, the product recalls of drug delivery devices leads to the temporary disruption in the production & distribution of the devices, which could be considered as the obstruction for market growth in the forecasted years. For instance, in 2021, Cardinal Health issued a nationwide recall of approximately 267 million Monoject Flush Prefilled saline syringes.
The report on the Autoimmune Disorder Drug Delivery Devices Market entails a detail-oriented analysis of the key aspects driving the market expansion in different segmentation & geographies. This section aims solely to enlighten the stakeholders & the leading players to plan & lay out new strategies for their visibility, product portfolio, & customer base, alongside the massive revenue generation & profits in the coming years. The section incorporates analysis in sub-division covering aspects like trends, developments, demand & supply chain, and product/service pricing, among others, in detail. Below cited are the different segments in the report:
- Rheumatoid Arthritis
- Multiple Sclerosis
- Inflammatory Bowel Diseases
- Systemic Lupus Erythematosus
- Diabetes Mellitus
- Others (Guillain Barre Syndrome, Grave’s Disease, etc.)
By Product Type
- Pre-Filled Syringes
By Manufacturing Type
- In-House Manufacturing
- Outsourced Manufacturing
Market Geographical Data
On the geographical front, the Autoimmune Disorder Drug Delivery Devices Market expands across the following region:
- North America
- South America
- Middle East & Africa
Of all the regions, North America gained a significant share in the Global Autoimmune Disorder Drug Delivery Devices market from 2022-2027 on account of rising research & development in the pharmaceutical sector as well as the growing prevalence of chronic ailments in the region. Furthermore, rapid industrialization & urbanization have contributed to an increase in adverse environmental conditions across several fields, including high temperatures, toxic chemical releases from industry, land degradation, expanding exploration activities, and lower quality & quantity of agricultural products.
This has impacted the natural living conditions of humans, resulting in nutrient deficiencies, toxic air quality, water contamination, etc., and has majorly supported the growth of autoimmune diseases in North America. According to the National Stem Cell Foundation (NCSF), autoimmune disease represents the third most common cause of chronic illnesses in the United States.
Schedule A Call With Our Expertise, For Any Question About This Study– Schedule A Call Now
Covid-19 Impact on the Autoimmune Disorder Drug Delivery Devices Industry
The outbreak of the Covid-19 pandemic made a relatively positive impact on the Global Autoimmune Disorder Drug Delivery Devices market The burgeoning requirement for drug delivery devices in hospitals & households to inject immunity boosters to COVID infected patients globally fueled the market demand for drug delivery devices. According to the National Institute for Health Research, ‘the spread of SARS-COV-2 has created long-term autoimmune complications, including the Guillain-Barre-Syndrome, which has spurred the demand for the development of autoimmune disorder drug delivery devices for enhanced patient recoveries in the global markets.
Report Full Table of Content
- Research Process
- Market Segmentation
- Market Definition
- Executive Summary
- Global Autoimmune Disorder Drug Delivery Devices Market Trends & Insights
- Global Autoimmune Disorder Drug Delivery Devices Market Regulation & Policy, By Country
- Global Autoimmune Disorder Drug Delivery Devices Market Dynamics
- Growth Drivers
- Impact Analysis
- Global Autoimmune Disorder Drug Delivery Devices Market Intellectual Property Rights Analysis
- Total Patents Filed
- By International Patent Classification (IPC)
- By Country
- By Competitors
- Global Autoimmune Disorder Drug Delivery Devices Market Hotspot and Opportunities
- Global Autoimmune Disorder Drug Delivery Devices Market Outlook, 2017- 2027
- Total Patents Filed
The study on Autoimmune Disorder Drug Delivery Devices Market brings together extensive research on the prominent players dominating the industry by rigorously profiling each company and their operations, product/service portfolio, mergers & acquisitions, expansion plans, recent developments, key strategies, and opportunities to attain higher profit margins. The leading players in the industry profiled in the report include the following:
- – Amgen Inc.
- – AbbVie Inc.
- – Bayer AG
- – Biogen Inc.
- – Eli Lilly and Company
- – Bristol-Myers Squibb Company
- – F. Hoffmann-La Roche AG
- – GlaxoSmithKline plc
- – Johnson & Johnson Services, Inc.
- – The Merck Group
- – Novartis International AG
- – Sanofi S.A.
- – Teva Pharmaceutical Industries Ltd.
- – UCB Pharma SA.
- – Others
We also offer customization services to the stakeholders on the Autoimmune Disorder Drug Delivery Devices Market, exhibiting a comprehensive analysis of the industry. The report incorporates the relevant aspects curating the fundamentals underlying the market potential and helping the stakeholders to make informed decisions & investments in the industry.
To Get the Benefit of Our Customization Report Service, Sent Your Enquiry Here – https://www.marknteladvisors.com/query/request-customization/global-autoimmune-disorder-drug-delivery-devices-market.html
Key Reasons to Buy the Report:
- The report reflects the fluctuating dynamics of the industry by focusing on all the growth drivers, restraints, opportunities, and challenges, among others.
- The stakeholders can attain detail-driven, accurate, and reliable information about the ongoing trends & recent developments in the market, alongside the rise & fall of the industry across each segment in different geographies.
- Using the insights of the study, the reader also gets a perspective on the competitive landscape of the market, alongside the prominent strategies, initiatives, developments, mergers & acquisitions, among other dynamics of the players for their sustainability & higher profit margins in the industry.
- Upon the finances, the analysis also offers estimates on the investments made by the key players & governments of different countries amidst the changing market interface.
Our Latest Press Release
About MarkNtel Advisors
We are a leading research, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.
Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.
Our Contact Details –
Phone – +1 628 895 8081, +91 120 4278433
Follow Us – Twitter, LinkedIn, Facebook, Pinterest
Read Blogs – www.marknteladvisors.com/blogs